2 This reflects a broader industry shift toward catering to the needs of individuals managing their weight with GLP-1 medications, emphasizing nutrient density and portion control
One of the most pressing regulatory issues in the GLP-1 space centers on compounded formulations, which have expanded access and affordability but fall outside the rigorous oversight applied to branded medications
We are learning that more aggressive treatment of what we considered borderline or even normal levels of glucose and blood pressure in the past are giving us improved obstetric outcomes during pregnancy
Attorneys who are taking on Ozempic claims are investigating different side effects and associated lawsuits: Gastroparesis: When someones stomach becomes paralyzed and does not move food through their digestive system Ileus: When partially digested food blocks or obstructs someones intestines Blindness or loss of sight (NAION) Pancreatitis or pancreatic cancer Thyroid tumors Deep vein thrombosis: Blood clots that form in deep veins, like those in the legs Pulmonary embolism: When a clot that forms somewhere else travels into your lungs and blocks the flow of blood Many people are suing Novo Nordisk, which manufactures Ozempic, because they think the company knew about the dangers of this semaglutide injection but did not tell consumers
The most common GLP-1 side effects are nausea, fatigue, and constipation, particularly during the first 46 weeks of dose escalation
If tiredness persists beyond several weeks or feels severe, a healthcare provider can help evaluate potential causes
